(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(-0.69%) $83.27
(-1.16%) $1.619
(-0.04%) $2 346.30
(-0.15%) $27.50
(0.10%) $923.00
(-0.10%) $0.934
(-0.02%) $11.02
(-0.13%) $0.799
(0.00%) $92.17
-2.97% HKD 9.48
Live Chart Being Loaded With Signals
The United Laboratories International Holdings Limited, an investment holding company, engages in the research, development, manufacture, distribution, and sale of pharmaceutical products...
Stats | |
---|---|
Dagens volum | 6.03M |
Gjennomsnittsvolum | 4.03M |
Markedsverdi | 17.23B |
EPS | HKD0 ( 2024-03-26 ) |
Last Dividend | HKD0.131 ( 2023-09-14 ) |
Next Dividend | HKD0 ( N/A ) |
P/E | 5.89 |
ATR14 | HKD0.0220 (0.23%) |
Volum Korrelasjon
United Laboratories Korrelasjon
10 Mest positive korrelasjoner |
---|
10 Mest negative korrelasjoner |
---|
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
United Laboratories Korrelasjon - Valuta/Råvare
United Laboratories Økonomi
Annual | 2023 |
Omsetning: | HKD13.74B |
Bruttogevinst: | HKD6.33B (46.11 %) |
EPS: | HKD1.490 |
FY | 2023 |
Omsetning: | HKD13.74B |
Bruttogevinst: | HKD6.33B (46.11 %) |
EPS: | HKD1.490 |
FY | 2022 |
Omsetning: | HKD11.33B |
Bruttogevinst: | HKD4.97B (43.84 %) |
EPS: | HKD0.870 |
FY | 2021 |
Omsetning: | HKD9.70B |
Bruttogevinst: | HKD4.21B (43.40 %) |
EPS: | HKD0.560 |
Financial Reports:
No articles found.
United Laboratories Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0.0801 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0.196 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | HKD0.156 | 2008-05-26 |
Last Dividend | HKD0.131 | 2023-09-14 |
Next Dividend | HKD0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 15 | -- |
Total Paid Out | HKD1.398 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.65 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 4.42 | |
Div. Directional Score | 7.66 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
8371.HK | Ex Dividend Junior | 2023-08-03 | Annually | 0 | 0.00% | |
2020.HK | Ex Dividend Knight | 2023-09-04 | Semi-Annually | 0 | 0.00% | |
1099.HK | Ex Dividend Junior | 2023-06-19 | Annually | 0 | 0.00% | |
0168.HK | Ex Dividend Knight | 2023-06-21 | Annually | 0 | 0.00% | |
3737.HK | Ex Dividend Junior | 2023-10-17 | Annually | 0 | 0.00% | |
1668.HK | No Dividend Player | 2023-09-26 | Annually | 0 | 0.00% | |
0710.HK | Ex Dividend Knight | 2023-07-05 | Annually | 0 | 0.00% | |
2230.HK | Ex Dividend Knight | 2023-09-21 | Semi-Annually | 0 | 0.00% | |
1243.HK | Ex Dividend Junior | 2023-08-25 | Annually | 0 | 0.00% | |
0308.HK | Ex Dividend Junior | 2023-09-18 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.197 | 1.500 | 6.07 | 9.10 | [0 - 0.5] |
returnOnAssetsTTM | 0.129 | 1.200 | 5.72 | 6.86 | [0 - 0.3] |
returnOnEquityTTM | 0.223 | 1.500 | 8.64 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 2.08 | 0.800 | 4.60 | 3.68 | [1 - 3] |
quickRatioTTM | 1.528 | 0.800 | 5.72 | 4.57 | [0.8 - 2.5] |
cashRatioTTM | 0.643 | 1.500 | 7.54 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.0714 | -1.500 | 8.81 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 0 | 1.000 | -1.111 | -1.111 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.659 | 2.00 | 9.78 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.400 | 2.00 | 9.80 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.118 | -1.500 | 9.53 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.461 | 1.000 | 5.65 | 5.65 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.231 | 1.000 | 7.38 | 7.38 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.798 | 1.000 | 6.68 | 6.68 | [0.2 - 2] |
assetTurnoverTTM | 0.654 | 0.800 | 8.98 | 7.18 | [0.5 - 2] |
Total Score | 10.90 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 5.90 | 1.000 | 9.51 | 0 | [1 - 100] |
returnOnEquityTTM | 0.223 | 2.50 | 9.12 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.400 | 2.00 | 9.87 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 2.24 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.659 | 2.00 | 9.78 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0 | 1.500 | -3.33 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0872 | 1.000 | -0.321 | 0 | [0.1 - 0.5] |
Total Score | 4.42 |
United Laboratories
The United Laboratories International Holdings Limited, an investment holding company, engages in the research, development, manufacture, distribution, and sale of pharmaceutical products. It operates through three segments: Bulk Medicine, Intermediate Products, and Finished Products. The company offers oral antibiotics, antimicrobials for injection, anti-cold products, cough medicines, ophthalmic drugs, antiviral drugs, anti-hepatitis B drugs, diabetes drugs, skin drugs for external use, cardiovascular and cerebrovascular drugs, nervous system drugs, vitamins, and vacant gelatin capsules, as well as API and intermediate products. It also manufactures and sells soft capsules casings; holds trademarks; and trades in pharmaceutical products. In addition, the company provides management services. It has operations in the People's Republic of China, Europe, India, the Middle East, South America, other Asian regions, and internationally. The company was founded in 1990 and is headquartered in Yuen Long, Hong Kong.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.